ONE Bio

ONBI

Biotechnology · Healthcare

Winston Score

Winston is curious

A decent business — some strong pillars, some weaker.

Data as of Aug 23, 2026 · filings through Sep 30, 2011

How the score breaks down

Quality

Strong

Growth

Mixed

Cash Flow

Exceptional

Stability

Strong

Valuation

Good

Track this stock — start free trial

Winston Score History

The full picture

ONE Bio Corp. is a small biotechnology company focused on developing biological and bio-based products. Biotechnology companies like this one use living organisms or biological processes to create products for industries such as healthcare, agriculture, or industrial applications. With a market cap near zero, ONE Bio Corp. is a micro-cap company in the early stages of building its business.

The company generates revenue across its product lines, reflected in a gross margin of roughly 38%, which suggests it retains a meaningful portion of each dollar it earns after direct costs. Its operating margin of about 26% indicates it is currently covering operating expenses, which is uncommon for small biotech firms. The main risk for a company this size is limited financial resources, which can make it difficult to fund research, scale operations, or compete against larger, better-funded rivals in the biotechnology space.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+0.3% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-25.8% YoY

YoY Growth Rate

Earnings declining

Insider Activity

7.5%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$14M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

ONE Bio is growing revenue at 0% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

42.5%

Healthy — 42.5% gross margin

Profit after running costs

Operating Margin

22.7%

Excellent — 22.7% operating margin

Return on the money invested

ROCE

19.9%

Strong — 19.9% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+6.1%

Slow sales growth (+6.1% YoY)

Profit growth

EPS YoY

-38.9%

Earnings shrinking (-38.9% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

127%

Turns 127% of profit into real cash

Spare cash per sale

FCF Margin

13.0%

Converts sales into free cash efficiently (13.0%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.53

Conservative — low debt load (0.53)

Covers its interest

Interest Cover

11.14x

Comfortably covers interest (11.1x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

0.0x

no trend

Attractive valuation — P/E 0.0

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial